Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 10481 - 500 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
Reset 

MemorialCare's Vice President of Clinical Integration Shines Bright in Modern Healthcare's 40 Under 40

Read more ››
By: PR Newswire Association LLC. - 12 Feb 2024
Related companies:  MemorialCare Innovation Fund

Liver Disease Therapeutics Competitive Landscape and Market Forecasts to 2028

Read more ››
By: PR Newswire Association LLC. - 12 Feb 2024

Checkpoint Inhibitors Market Forecast Reveals Impressive Growth With Focus on Novel Therapies and Regional Expansion

Read more ››
By: PR Newswire Association LLC. - 12 Feb 2024

Workind Appoints its First Board of Directors

Read more ››
By: PR Newswire Association LLC. - 12 Feb 2024

BioVaxys Acquires All Intellectual Property, Immunotherapeutics Platform Technology, and Clinical Stage Assets of the Former IMV Inc.

Read more ››
By: PR Newswire Association LLC. - 12 Feb 2024
Related companies:  BioVaxys Technology Corporation

Neighbourly Announces Filing of Special Meeting Materials and Receipt of Interim Order in Respect of Go-Private Arrangement with Persistence Capital Partners

Read more ››
By: PR Newswire Association LLC. - 12 Feb 2024

Immunovant Reports Financial Results and Provides Corporate Updates for the Quarter Ended December 31, 2023

Read more ››
By: GlobeNewswire - 12 Feb 2024

MediWound Announces Positive Results in Head-to-Head Comparison of EscharEx® vs. SANTYL® within the ChronEx Phase II Randomized Controlled Study

Read more ››
By: GlobeNewswire - 12 Feb 2024
Related companies:  MediWound Ltd.

Larimar Therapeutics Reports Positive Top-line Data from Phase 2 Dose Exploration Study from 25 mg and 50 mg Cohorts of Nomlabofusp in Patients with Friedreich’s Ataxia

Read more ››
By: GlobeNewswire - 12 Feb 2024
Related companies:  Larimar Therapeutics, Inc.

InspireMD Appoints Principal Investigators for C-GUARDIANS II Clinical Trial of the SwitchGuard™ Neuroprotection System

Read more ››
By: GlobeNewswire - 12 Feb 2024
Related companies:  InspireMD, Inc.

PolyPid Announces Enrollment of the 100th Patient in the Ongoing SHIELD II Phase 3 Trial

Read more ››
By: GlobeNewswire - 12 Feb 2024
Related companies:  PolyPid Ltd.

Gritstone bio Announces Update to Comparative Phase 2b COVID-19 Clinical Trial

Read more ››
By: GlobeNewswire - 12 Feb 2024
Related companies:  Gritstone bio

BioCryst to Report Fourth Quarter 2023 Financial Results on February 26

Read more ››
By: GlobeNewswire - 12 Feb 2024
Related companies:  BioCryst Pharmaceuticals, Inc.

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons

Read more ››
By: GlobeNewswire - 12 Feb 2024

BioXcel Therapeutics Receives FDA Fast Track Designation for BXCL701 for Treatment of Small Cell Neuroendocrine Prostate Cancer (SCNC)

Read more ››
By: GlobeNewswire - 12 Feb 2024
Related companies:  BioXcel Therapeutics, Inc.

Organogenesis Holdings Inc. to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference

Read more ››
By: GlobeNewswire - 12 Feb 2024
Related companies:  Organogenesis Holdings Inc.

VitalHub Announces First Canadian Licensing Agreement of the Award-Winning Intouch with Health Queue Management & Patient Journey Optimization Platform with Newfoundland & Labrador Health Services

Read more ››
By: GlobeNewswire - 12 Feb 2024
Related companies:  VitalHub Corp

IBEX Technologies Signs Definitive Agreement for Sale of the Company for $1.45 Cash Per Share

Read more ››
By: GlobeNewswire - 12 Feb 2024
Related companies:  IBEX Technologies Inc.

4DMT Presents Interim Data from 4D-310 INGLAXA Phase 1/2 Clinical Trials for Fabry Disease Cardiomyopathy at WORLDSymposium™ 2024

Read more ››
By: GlobeNewswire - 12 Feb 2024
Related companies:  4D Molecular Therapeutics, Inc.

Adverum Biotechnologies to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Read more ››
By: GlobeNewswire - 12 Feb 2024
Related companies:  Adverum Biotechnologies, Inc.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
to the top ↑